Beatriz Pires da Silva | Parasitology | Best Researcher Award

Published on by Zoology Honour

Ms. Beatriz Pires da Silva | Parasitology | Best Researcher Award

Master’s student in Parasitic Biology at Oswaldo Cruz Institute, Brazil

Beatriz Pires da Silva is a passionate biomedical scientist and Master’s student in Parasitic Biology at the Oswaldo Cruz Institute (Fiocruz), Brazil 🧪. From her undergraduate days, she has worked closely with the Malaria Research Laboratory (LPM), a reference center in the extra-Amazon region 🇧🇷. Beatriz’s early scientific contributions focus on zoonotic malaria transmission and molecular diagnostic markers for Plasmodium falciparum. Her first-author publication has contributed to raising awareness of lesser-known transmission pathways of malaria in Brazil, with implications for public health policies. She has collaborated with respected international scientists such as Didier Menard and George Snounou 🌍. Though at the beginning of her career, Beatriz exhibits exceptional dedication to research, public health, and scientific development. Her goal is to continue building knowledge that supports malaria control, elimination, and innovation through evidence-based molecular research and collaborative science 🤝.

Professional Profiles📖

ORCID

Education 🎓

Beatriz Pires da Silva is currently pursuing a Master’s degree in Parasitic Biology at the Oswaldo Cruz Institute / Fiocruz in Rio de Janeiro, Brazil 📘. Her educational journey began during her undergraduate studies in Biomedical Sciences, where she engaged in research at the Malaria Research Laboratory (LPM), a leading center for malaria studies in the Brazilian extra-Amazon region 🔬. During this time, she was actively involved in molecular diagnostic activities, gaining hands-on training in techniques crucial to infectious disease analysis. Her graduation thesis focused on zoonotic malaria transmission and has since evolved into a published scientific article 📝. Through her academic path, Beatriz has demonstrated a commitment to mastering the molecular aspects of parasitology and developing research that bridges field data with laboratory science. She continues to expand her academic skills in genetics, epidemiology, and malaria diagnosis, setting a strong foundation for a career in tropical disease research 🌿.

Work Experience💼

Beatriz’s research experience began at the Malaria Research Laboratory (LPM), where she worked during her undergraduate years as a student researcher 👩‍🔬. She actively participated in the molecular diagnosis routine at CPD-Mal (Malaria Research, Diagnosis, and Training Center), gaining valuable practical exposure to real-time diagnostics, PCR, and gene analysis 🧬. Her main contribution during this time was compiling and analyzing data related to zoonotic malaria transmission in Brazil’s extra-Amazon region — a project that led to her first scientific publication. Currently, she is researching deletions and mutations in the pfhrp2 and pfhrp3 genes in Plasmodium falciparum, which are vital for improving rapid diagnostic tests in Brazil ⚕️. Although early in her career, Beatriz has already formed international collaborations and contributed meaningfully to understanding malaria transmission patterns. Her experience reflects a blend of laboratory precision, scientific writing, data interpretation, and an evolving understanding of global parasitic diseases 🌎.

Awards and Honors 🏆

As a rising early-career researcher, Beatriz Pires da Silva is now entering the stage of her academic journey where formal recognitions are beginning to emerge 🌟. While she has not yet received major individual awards, her recent first-author publication and active research involvement at one of Brazil’s premier public health institutions (Fiocruz) are testaments to her growing impact 🧬. Her collaborations with leading global malaria experts such as Didier Menard and George Snounou are prestigious achievements that reflect her research potential. Beatriz’s current nomination for the Best Researcher Award stands as her first significant external recognition — highlighting her commitment to science, molecular innovation, and public health improvement. As her publication count grows and her research reaches broader audiences, she is poised to earn academic and scientific honors in the near future for her efforts in neglected tropical diseases and molecular parasitology 🏆.

Skills💡

Beatriz Pires da Silva brings a strong foundation in molecular biology techniques including DNA extraction, PCR, gel electrophoresis, and molecular diagnostics 🧪. She is skilled in scientific literature review, data analysis, and academic writing, as demonstrated by her first-author publication in the area of zoonotic malaria 📖. Her analytical thinking, precision in lab work, and structured approach to scientific inquiries allow her to handle complex datasets and molecular evidence efficiently. Beatriz is also adept at collaborating across disciplines and engaging with international research teams 🤝. Her experience at CPD-Mal equipped her with practical knowledge in real-time diagnostics and laboratory routines for parasitic diseases. Additionally, she is developing competencies in bioinformatics and gene analysis tools, specifically in studying genetic deletions in Plasmodium falciparum. Bilingual communication (Portuguese and English) adds to her strengths, enabling global academic collaboration. She continues to expand her skill set to support research excellence and innovation 🌐.

Research Focus 🔬

Beatriz Pires da Silva’s research is centered on the molecular biology of malaria, with particular attention to zoonotic transmission and gene deletions affecting diagnostic tools 🔍. Her first major contribution involved a review of zoonotic malaria in Brazil’s extra-Amazon region, where she synthesized ecological, entomological, and molecular data to clarify underreported transmission pathways 🦟. This work addresses a gap in malaria control strategies and has implications for Brazil’s elimination goals. Currently, Beatriz is investigating deletions in the pfhrp2 and pfhrp3 genes of Plasmodium falciparum, which can impair the accuracy of rapid diagnostic tests (RDTs) — a key issue in malaria diagnosis and treatment 📊. Her research bridges molecular genetics, epidemiology, and diagnostic innovation, reflecting a multidisciplinary and impactful approach to parasitic disease management. With strong analytical skills and a commitment to applied science, Beatriz is contributing to more effective public health interventions through molecular-level insights 🧫.

Conclusion✅

Beatriz Pires da Silva, although at the beginning of her academic career, demonstrates remarkable promise, rigor, and a deep commitment to solving real-world challenges in malaria research. Her work already contributes to an underrepresented but vital domain — zoonotic malaria — and has implications for national health strategies. While not yet seasoned enough to compete with established senior researchers for the “Best Researcher Award,” she stands out as an exceptional candidate for an early-career or emerging researcher category. Her profile suggests a bright future marked by meaningful contributions to parasitology and global health.

Publications Top Notes📚

Publication Title: Autochthonous malaria in Brazil outside the Amazon: Emergence, zoonotic transmission and implications for disease control

Journal: One Health

Publication Date: December 2024

DOI: 10.1016/j.onehlt.2024.100928

Glory Adebayo | Parasitology | Best Researcher Award

Published on by Zoology Honour

Ms. Glory Adebayo | Parasitology | Best Researcher Award

Research Associate at Nigerian Institute of Medical Research, Nigeria

Glory Pipeloluwa Adebayo is a dedicated biomedical researcher specializing in molecular biology, bioinformatics, and malaria drug discovery. She is currently a Research Fellow at the Nigerian Institute of Medical Research (NIMR), where she leads studies on Plasmodium falciparum resistance and antimalarial therapeutics. With extensive expertise in molecular diagnostics, immunology, and in vitro drug assays, she has contributed significantly to infectious disease research. Her work has resulted in multiple high-impact publications, and she has trained several young scientists in laboratory techniques. She has also participated in international research collaborations, including training at the Swiss Tropical and Public Health Institute. Her contributions to malaria research extend to both computational and laboratory-based studies, making her a prominent figure in the field. She aspires to develop innovative treatment strategies for infectious diseases through interdisciplinary research and technological advancements.

Professional Profiles📖

Scopus

Education 🎓

Glory is a dedicated researcher with a strong academic background in biological sciences. She earned her B.Sc. (Hons) in Biochemistry from the University of Lagos, Nigeria, with a commendable GPA of 4.08/5.00. She then pursued an M.Sc. in Cell Biology and Genetics at the same institution, graduating with a stellar GPA of 4.29/5.00. Currently, she is completing her Ph.D. in Biology at Covenant University, where her research is centered on antimalarial drug discovery. Her work integrates both computational and laboratory-based approaches to experimental drug development, positioning her at the forefront of innovative biomedical research. Beyond her academic achievements, Glory has gained valuable hands-on experience, including her service at the Abia State Hospital and Diagnostic Centre during her National Youth Service Corps (NYSC) year. She has honed her expertise in molecular techniques, bioinformatics, and pharmaceutical research, contributing to international collaborations, conference presentations, and high-impact scientific publications. With a passion for advancing global health through cutting-edge research, she remains committed to making significant contributions to drug discovery and disease treatment.

Awards and Honors 🏆

Glory’s dedication to research, international collaboration, and academic excellence in biomedical sciences is evident through her numerous prestigious awards and fellowships. In 2024, she was awarded a Research Fellowship at the Nigerian Institute of Medical Research (NIMR), recognizing her contributions to malaria therapeutic efficacy studies and molecular diagnostics. Her commitment to global health research was further acknowledged in 2022 when she received the Swiss TPH Training Fellowship at the Swiss Tropical and Public Health Institute, where she honed her expertise in Plasmodium falciparum drug assays and mammalian cell culture techniques. Earlier in her career, Glory was recognized as the Best Graduate Research Intern at NIMR in 2019 for her outstanding work in molecular diagnosis and Plasmodium resistance studies. Her academic excellence was also celebrated at the University of Lagos, where she received the Academic Excellence Award in 2016. These accolades highlight her passion for scientific discovery, her ability to excel in competitive research environments, and her ongoing contributions to biomedical science and infectious disease research.

Work Experience💼

Glory’s research experience spans academia, public health institutions, and international research centers, showcasing her interdisciplinary expertise in infectious disease research. Currently serving as a Research Fellow at the Nigerian Institute of Medical Research (NIMR), she leads malaria therapeutic efficacy studies, molecular diagnostics, and ELISA-based immunological assessments. Prior to this, she worked as a Research Assistant at Covenant University’s Bioinformatics Research Unit, where she conducted Plasmodium and mammalian cell cultures, toxicity assays, and molecular docking analyses. Her commitment to advancing malaria research led her to the Swiss Tropical & Public Health Institute in 2022, where she received specialized training in Plasmodium falciparum drug assays and mammalian cell culture techniques. She also gained hands-on experience as a Graduate Research Intern at NIMR in 2019, assisting in the molecular diagnosis of human blood samples and Plasmodium resistance studies. Beyond her research-focused roles, she worked as a Pharmacy Assistant at Crest Health Pharmacy in 2017, managing drug inventory and supporting pharmaceutical services. With a solid foundation in both laboratory and clinical research, Glory continues to contribute meaningfully to global infectious disease control efforts.

Skills💡

Glory possesses a diverse skill set that spans molecular biology, cell culture, immunology, bioinformatics, animal studies, lab management, and scientific writing. Her expertise in molecular biology includes DNA/RNA extraction, PCR, gel electrophoresis, and molecular docking, enabling her to conduct precise genetic and protein-based analyses. She is also proficient in cell culture techniques, working with Plasmodium and mammalian cells to perform in vitro drug assays that contribute to antimalarial drug discovery. Her immunology experience includes ELISA-based assays and serological testing, crucial for evaluating immune responses in infectious disease research. In bioinformatics, she specializes in data mining, next-generation sequencing (NGS) analysis, and omics data integration, allowing her to analyze large-scale biological data sets. Additionally, she has hands-on experience with murine malaria models, conducting toxicity assays and drug efficacy testing to validate therapeutic interventions. Beyond her technical skills, Glory is adept at lab management, ensuring compliance with safety protocols, maintaining accurate data records, and developing standard operating procedures (SOPs). She is also an accomplished scientific writer, with experience in manuscript preparation, grant writing, and proposal development, reinforcing her ability to contribute to high-impact research publications and secure funding for innovative projects.

Research Focus 🔬

Glory Adebayo is a dedicated researcher specializing in malaria research, with a focus on molecular drug discovery, Plasmodium resistance characterization, and bioinformatics applications. Her work integrates computational drug design, in vitro and in vivo antimalarial assays, and genetic analysis of resistant strains to advance the fight against malaria. She is particularly interested in post-GWAS (genome-wide association study) analysis, where she develops omics-based tools to study malaria epidemiology and identify potential therapeutic targets.

Beyond malaria research, Glory has contributed to studies on viral infections and antimicrobial resistance, expanding her impact within infectious disease research. Her interdisciplinary approach seamlessly combines wet-lab techniques with computational biology, enabling her to bridge experimental and computational methodologies. Through her research, she aims to develop effective therapeutics and innovative strategies to combat infectious diseases, ultimately improving global public health outcomes.

Publications Top Notes📚

 

Title: The Importance of Murine Models in Determining In Vivo Pharmacokinetics, Safety, and Efficacy in Antimalarial Drug Discovery.​

Journal: Pharmaceuticals.​Preprints+1MDPI+1

Publication Date: March 2025.​

DOI: 10.3390/ph18030424.

Peng Teng | Biotechnology | Best Researcher Award

Published on by Zoology Honour

Assist. Prof. Dr. Peng Teng | Biotechnology | Best Researcher Award

Principal Investigator at Zhejiang University, China 

Dr. Peng Teng is an an accomplished scientist specializing in medicinal chemistry, drug discovery, and bioorganic chemistry. Currently serving as an Assistant Professor (Tenure-Track) at Zhejiang University, he has made significant contributions to the field of peptidomimetics, protein-protein interactions, and antimicrobial drug development. With an H-index of 29, he has authored numerous high-impact publications. Before joining Zhejiang University, Dr. Teng held research positions at the University of Wisconsin–Madison and the University of South Florida. His expertise spans synthetic chemistry, carbohydrate chemistry, and bioconjugation strategies for targeted therapeutics. Dr. Teng’s work has earned international recognition, influencing novel approaches in protein degradation and antibacterial drug design. His research is dedicated to developing next-generation therapeutic agents to combat bacterial resistance and improve human health.

Professional Profiles📖

ORCID

Education 🎓

Dr. Teng pursued his Ph.D. in Medicinal Chemistry at Nanjing University, where he worked under Prof. Jianxin Li at the State Key Laboratory of Analytical Chemistry for Life Science. Concurrently, he earned an M.S. in Chemistry from Lanzhou University, guided by Prof. Yongmin Liang. He further honed his research skills as a Postdoctoral Associate at the University of South Florida under Prof. Jianfeng Cai, exploring peptidomimetics and bioorganic chemistry. His academic journey continued at the University of Wisconsin–Madison as an Assistant Scientist, collaborating with Prof. Weiping Tang in drug discovery and protein degradation. His diverse educational background provided a strong foundation in synthetic chemistry, drug design, and biochemical applications, setting the stage for his pioneering contributions to antimicrobial and anticancer therapeutics.

Work Experience💼

Dr. Teng’s professional journey spans academia and industry. At Zhejiang University, he leads research at the Institute of Drug Discovery and Design, focusing on novel therapeutics for bacterial infections and protein interactions. Prior to this, he was an Assistant Scientist at the University of Wisconsin–Madison, where he worked on targeted protein degradation strategies. His postdoctoral tenure at the University of South Florida involved developing antimicrobial peptidomimetics. Earlier, he gained industry experience at WuXi AppTec as a Senior Organic Chemist, working on medicinal chemistry projects under Dr. Yang Zhang. His interdisciplinary experience bridges synthetic chemistry, bioorganic chemistry, and pharmaceutical applications, contributing to the advancement of innovative therapeutic strategies.

Awards and Honors 🏆

Dr. Teng has received numerous accolades for his groundbreaking research. His publications have been featured in high-impact journals like JACS, Angewandte Chemie, and ACS Med. Chem. Lett. He was recognized for his contributions to antimicrobial drug discovery, with a cover feature in JACS. His research has been highlighted by the USF Chemistry News and other prestigious scientific platforms. Additionally, he has been invited to speak at international conferences on medicinal chemistry and drug development. His innovative work on peptidomimetic antibiotics has earned funding and collaborative opportunities with global research institutions.

Skills💡

Dr. Teng is a highly skilled chemist with expertise spanning synthetic, medicinal, and bioorganic chemistry. With a strong foundation in organic synthesis, peptide synthesis, and peptidomimetics, they have contributed to the development of novel molecules with therapeutic potential. Their work in medicinal chemistry focuses on drug discovery and structure-activity relationship (SAR) studies, optimizing lead compounds for enhanced efficacy and selectivity. Additionally, their research in bioorganic chemistry involves bioconjugation, enzyme inhibition, and carbohydrate chemistry, facilitating the design of innovative biochemical tools and therapeutics. A key area of interest is protein-protein interactions, where aims to disrupt or modulate critical biological pathways for therapeutic applications. They have also made significant contributions to antimicrobial drug design, working on the development of novel antibiotics and resistance modulators to combat emerging bacterial threats. Their expertise in computational chemistry, including molecular modeling, docking, and structure-based drug design, complements their experimental work by guiding rational drug development strategies, is proficient in a range of analytical techniques, including NMR, mass spectrometry, X-ray crystallography, and HPLC, ensuring precise characterization of chemical and biological entities. With a strong background in leadership and collaboration, they have successfully led interdisciplinary research projects and international partnerships, fostering innovation at the intersection of chemistry and biomedical sciences.

Research Focus 🔬

Dr. Teng’s research focuses on medicinal chemistry, bioorganic chemistry, and drug discovery. He specializes in peptidomimetics, targeting protein-protein interactions for novel therapeutic applications. His work involves developing antimicrobial agents, protein degradation strategies, and carbohydrate-based drug designs. He is particularly interested in addressing bacterial resistance through synthetic small molecules and biomimetic approaches. His research integrates chemical synthesis, biophysical characterization, and molecular modeling to engineer effective therapeutics. His contributions to the field of targeted protein degradation and synthetic foldamers have opened new avenues for precision medicine and next-generation drug development.

Conclusion✅

Dr. Peng Teng is a highly deserving candidate for the Best Researcher Award due to his strong publication record, innovative research, and contributions to drug discovery. While there is room for further impact through commercialization and funding acquisition, his scientific achievements position him as a leading researcher in his field.

Publications Top Notes📚

 

N-Heterocyclic Carbene-Catalyzed Highly Enantioselective Macrolactonization to Access Planar-Chiral Macrocycles

Journal: Organic Letters

Year: 2024

DOI: 10.1021/acs.orglett.3c04200

Rational Design of Sulfonyl-γ-AApeptides as Highly Potent HIV-1 Fusion Inhibitors with Broad-Spectrum Activity

Journal: Journal of Medicinal Chemistry

Year: 2023

DOI: 10.1021/acs.jmedchem.3c01412

Small Molecular Mimetics of Antimicrobial Peptides as a Promising Therapy To Combat Bacterial Resistance

Journal: Journal of Medicinal Chemistry

Year: 2023

DOI: 10.1021/acs.jmedchem.2c00757

The Folding Propensity of α/Sulfono-γ-AA Peptidic Foldamers with Both Left- and Right-Handedness

Journal: Communications Chemistry

Year: 2021

DOI: 10.1038/s42004-021-00496-0

Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins

Journal: ACS Central Science

Year: 2021

DOI: 10.1021/acscentsci.1c00146

Lipidated α/Sulfono-α-AA Heterogeneous Peptides as Antimicrobial Agents for MRSA

Journal: Bioorganic & Medicinal Chemistry

Year: 2020

DOI: 10.1016/j.bmc.2019.115241

Molecular Architecture and Charging Effects Enhance the In Vitro and In Vivo Performance of Multi‐Arm Antimicrobial Agents Based on Star‐Shaped Poly( l ‐lysine)

Journal: Advanced Therapeutics

Year: 2019

DOI: 10.1002/adtp.201900147

Orthogonal Halogen‐Bonding‐Driven 3D Supramolecular Assembly of Right‐Handed Synthetic Helical Peptides

Journal: Angewandte Chemie

Year: 2019

DOI: 10.1002/ange.201903259

Development of EGFR-targeted Evodiamine Nanoparticles for the Treatment of Colorectal Cancer

Journal: Biomaterials Science

Year: 2019

DOI: 10.1039/c9bm00613c

Nano-Sized Lipidated Dendrimers as Potent and Broad-Spectrum Antibacterial Agents

Journal: Macromolecular Rapid Communications

Year: 2018

DOI: 10.1002/marc.201800622

De Novo Left‐Handed Synthetic Peptidomimetic Foldamers

Journal: Angewandte Chemie

Year: 2018

DOI: 10.1002/anie.201805184

Bis‐Cyclic Guanidines as a Novel Class of Compounds Potent against Clostridium difficile

Journal: ChemMedChem

Year: 2018

DOI: 10.1002/cmdc.201800240

Lipidated α/α-AA Heterogeneous Peptides as Antimicrobial Agents

Journal: European Journal of Medicinal Chemistry

Year: 2018

DOI: 10.1016/j.ejmech.2018.06.006

Selective Inhibition of Leukemia-Associated SHP2E69K Mutant by the Allosteric SHP2 Inhibitor SHP099

Journal: Leukemia

Year: 2018

DOI: 10.1038/s41375-018-0020-5

Hydrogen-Bonding-Driven 3D Supramolecular Assembly of Peptidomimetic Zipper

Journal: Journal of the American Chemical Society

Year: 2018

DOI: 10.1021/jacs.7b11997

Right-Handed Helical Foldamers Consisting of De Novo D‑AApeptides

Journal: Journal of the American Chemical Society

Year: 2017

DOI: 10.1021/jacs.7b03007

Antimicrobial AApeptides

Journal: Current Topics in Medicinal Chemistry

Year: 2017

DOI: 10.2174/1568026616666161018145945

Membrane-Active Hydantoin Derivatives as Antibiotic Agents

Journal: Journal of Medicinal Chemistry

Year: 2017

DOI: 10.1021/acs.jmedchem.7b00847

Novel Bis-Cyclic Guanidines as Potent Membrane-Active Antibacterial Agents with Therapeutic Potential

Journal: Chemical Communications

Year: 2017

DOI: 10.1039/C7CC07285F

γ-AApeptides: Design, Structure, and Applications

Journal: Accounts of Chemical Research

Year: 2016

DOI: 10.1021/acs.accounts.5b00492

Lin Zhou | Diseases | Excellence in Innovation

Published on by Zoology Honour

prof. Dr. Lin Zhou | Diseases | Excellence in Innovation

Dr  at Guangdong Pharmaceutical University, China

Lin Zhou is a distinguished professor in the Bioengineering Department at Guangdong Pharmaceutical University, China. With a strong background in carbohydrate engineering and fermentation technology, he has significantly contributed to the fields of bioactive substances, phytochemicals, and microbial metabolites. His research spans various biomedical applications, particularly in food science and chronic metabolic diseases. Having worked as a lecturer, associate professor, and professor at GDPU, he has led multiple national and industry-funded research projects. Lin Zhou’s expertise lies in antioxidant, anti-tumor, and anti-aging properties of bioactive substances. His scientific contributions are widely recognized, with numerous publications in high-impact journals. Apart from academia, he has experience in industrial fermentation engineering, reflecting his practical approach to biotechnology research. His work continues to influence advancements in pharmaceutical and food sciences, earning him prestigious awards in science and technology.

Professional Profiles📖

ORCID

Education 🎓

Ph.D. in Carbohydrate Engineering (2006) – South China University of Technology (SCUT), Guangzhou, China, under the guidance of Prof. Siyuan Guo.

Master to Ph.D. Direct Track (2001-2006) – South China University of Technology.

B.S. in Fermentation Engineering (1995-1999) – Hubei University of Technology (HBUT).

Work Experience💼

2018-2019 – Visiting Scholar, CSIRO, Melbourne, Australia.

2014-2017 – Postdoctoral Researcher, South China University of Technology.

2006-Present – Professor, Guangdong Pharmaceutical University.

2011-2012 – Scientific Special Commissioner, Guangdong Province.

2000-2001 – Workshop Manager, HeChengFeng Food and Beverage Ltd, China.

1999-2000 – Workshop Manager, ChuTe Food and Beverage Ltd, China.

Awards and Honors 🏆

First Prize in Science and Technology (2024) – Provincial High-Tech Enterprise Association, Guangdong, China.

Second Prize in Science and Technology (2024) – Provincial Light Industry Council, Guangdong, China.

Skills 💡

Bioactive Compound Analysis

Fermentation Technology

Microbial Metabolite Research

Pharmaceutical Biotechnology

Food Science and Engineering

Scientific Writing and Research Management

Innovation in Biopharmaceuticals

Research Focus 🔬

Lin Zhou specializes in the functional study of bioactive substances, emphasizing phytochemicals and microbial metabolites. His research explores the antioxidant, anti-tumor, and anti-aging potential of natural compounds, contributing to biomedical sciences. His work intersects microbiology, food science, and pharmaceuticals, leading industry-oriented research and collaborations. He has participated in China’s National Key R&D Program and led multiple industry-funded projects, making significant contributions to applied biotechnology.

Conclusion✅

Prof. Lin Zhou is a strong candidate for the Excellence in Innovation Award due to his extensive contributions to bioengineering, pharmaceutical sciences, and food biotechnology. His research has significantly advanced knowledge in metabolic disease treatment and bioactive substances, making him a worthy recipient of this recognition. Enhancing commercialization efforts and expanding global collaborations could further elevate his profile in scientific innovation.

Publications Top Notes📚

“Piggyback Crowdsensing (PCS): Energy Efficient Crowdsourcing of Mobile Sensor Data by Exploiting Smartphone App Opportunities”
Citations: 224
Year: 2013

“Cutting the Cord: A Robust Wireless Facilities Network for Data Centers”
Citations: 83
Year: 2014

“On the Validity of Geosocial Mobility Traces”
Citations: 78
Year: 2013

“Voting by Committees”
Citations: 435
Year: 1991

“On a Conjecture by Gale About One-Sided Matching Problems”
Citations: 357
Year: 1990

“A New Bargaining Set of an N-Person Game and Endogenous Coalition Formation”
Citations: 174
Year: 1994

“Atomic-Scale Characterization of Dilute Dopants in Topological Insulators via STEM–EDS Using Registration and Cell Averaging Techniques”
Year: 2024

“Sub-Lexical Phonological and Semantic Processing of Semantic Radicals: A Primed Naming Study”
Citations: 57
Year: 2013

“A Chinese Text Input Brain–Computer Interface Based on the P300 Speller”
Citations: 50
Year: 2012

“Pre-Lexical Phonological Processing in Reading Chinese Characters: An ERP Study”
Citations: 36
Year: 2014

“Measuring Megaregional Structure in the Pearl River Delta by Mobile Phone Signaling Data: A Complex Network Approach”
Citations: 76
Year: 2020

“Actors and Network in the Marketization of Rural Collectively-Owned Commercial Construction Land (RCOCCL) in China: A Pilot Case of Langfa, Beijing”
Citations: 31
Year: 2020

“Efficiency and Equality of the Multimodal Travel Between Public Transit and Bike-Sharing Accounting for Multiscale”
Citations: 10
Year: 2024